Skip to main content
. 2023 Jun 20;13(12):2128. doi: 10.3390/diagnostics13122128

Table 2.

Patient characteristics (n = 553).

Rivaroxaban Apixaban Edoxaban All
Patients (n/%) 300 (54.3) 221 (40.0) 32 (5.7) 553 (100)
Age (median/IQR) 74 (63–83) 78 (67–82) 75 (58–81) 76 (65–82)
Female sex (n/%) 126 (40.1) 86 (39.8) 10 (32.3) 222 (40.1)